Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

July 10, 2020

Kymera Therapeutics, Sanofi collaborate to advance novel protein degrader therapies to patients

Kymera Therapeutics announced the company has entered into a multi-program strategic collaboration with Sanofi to develop and commercialise first-in-class protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases.

Kymera Therapeutics, Sanofi collaborate to advance novel protein degrader therapies to patients